NTPDase8 protects mice from intestinal inflammation by limiting P2Y


Journal

Gut
ISSN: 1468-3288
Titre abrégé: Gut
Pays: England
ID NLM: 2985108R

Informations de publication

Date de publication:
01 2022
Historique:
received: 19 02 2020
revised: 29 12 2020
accepted: 04 01 2021
pubmed: 17 1 2021
medline: 11 1 2022
entrez: 16 1 2021
Statut: ppublish

Résumé

Nucleotides are danger signals that activate inflammatory responses via binding P2 receptors. The nucleoside triphosphate diphosphohydrolase-8 (NTPDase8) is an ectonucleotidase that hydrolyses P2 receptor ligands. We investigated the role of NTPDase8 in intestinal inflammation. We generated NTPDase8-deficient ( NTPDase8 is the dominant enzyme responsible for the hydrolysis of nucleotides in the lumen of the colon. Compared with wild-type (WT) control mice, the colon of NTPDase8 protects the intestine from inflammation most probably by limiting the activation of P2Y

Identifiants

pubmed: 33452178
pii: gutjnl-2020-320937
doi: 10.1136/gutjnl-2020-320937
doi:

Substances chimiques

Cytokines 0
Isothiocyanates 0
N,N''-1,4-butanediylbis(N'-(3-isothiocyanatophenyl))thiourea 0
RNA, Messenger 0
Receptors, Purinergic P2 0
purinoceptor P2Y6 0
Dextran Sulfate 9042-14-2
Adenosine Triphosphatases EC 3.6.1.-
nucleoside triphosphate diphosphohydrolase 8, mouse EC 3.6.1.3
Thiourea GYV9AM2QAG

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-54

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Mabrouka Salem (M)

Dép de microbiologie-infectiologie et d'immunologie, fac de médecine, Université Laval, Quebec City, QC, Canada.
Axe Maladies infectieuses et immunitaires, CHU de Québec - Université Laval, Quebec City, QC, Canada.

Joanna Lecka (J)

Axe Maladies infectieuses et immunitaires, CHU de Québec - Université Laval, Quebec City, QC, Canada.

Julie Pelletier (J)

Axe Maladies infectieuses et immunitaires, CHU de Québec - Université Laval, Quebec City, QC, Canada.

Danielle Gomes Marconato (D)

Dép de microbiologie-infectiologie et d'immunologie, fac de médecine, Université Laval, Quebec City, QC, Canada.
Axe Maladies infectieuses et immunitaires, CHU de Québec - Université Laval, Quebec City, QC, Canada.

Aline Dumas (A)

Axe Neurosciences, CHU de Québec - Université Laval, Quebec city, QC, Canada.

Luc Vallières (L)

Axe Neurosciences, CHU de Québec - Université Laval, Quebec city, QC, Canada.
Dép de médecine moléculaire, fac de médecine, Université Laval, Quebec City, QC, Canada.

Gaetan Brochu (G)

CHU de Québec - Université Laval, Quebec City, QC, Canada.
Dept. of Surgery, Université Laval, Quebec City, QC, Canada.

Bernard Robaye (B)

Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire, Université Libre de Bruxelles, Bruxelles, Belgium.

Christian Jobin (C)

Dept of Infectious Diseases & Pathology, University of Florida, Gainesville, Florida, USA.

Jean Sévigny (J)

Dép de microbiologie-infectiologie et d'immunologie, fac de médecine, Université Laval, Quebec City, QC, Canada jean.sevigny@crchudequebec.ulaval.ca.
Axe Maladies infectieuses et immunitaires, CHU de Québec - Université Laval, Quebec City, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH